Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
01/08/20178:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces DSUVIA™ as Brand Name for ARX-04 in the United StatesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/13/20167:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/13/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Submits New Drug Application for ARX-04 for the Treatment of Moderate-To-Severe Acute PainNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/06/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Reports on ARX-04 Market and Landscape Presented at Analyst & Investor EventNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/01/20168:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/28/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Updates Agenda for Analyst & Investor Event Focusing on Innovative Therapies for Treatment of Acute Pa...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/17/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Unveiling Results of ARX-04 SAP303 Study in Post-Operative Setting at the Annual ASRA Pain Medicine Me...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/09/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Host Analyst & Investor Event on December 1, 2016NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/08/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in NovemberNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/03/20166:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/02/20166:07AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/01/20164:08PMPR Newswire (US)AcelRx Pharmaceuticals Provides Corporate Update and Reports Third Quarter and Nine Months 2016 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/31/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present ARX-04 Analysis for Treatment of Moderate-to-Severe Acute Pain in Obese Patients at The Obe...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/25/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Tuesday, November 1st, 2016NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/24/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Presenting ARX-04 Clinical Trial Findings at National Conference on Correctional Health CareNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/03/20164:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/30/20164:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/28/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Presenting ARX-04 Clinical Trial Findings and Cost Analysis at European Congress on Emergency MedicineNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/27/20167:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/27/20167:00AMPR Newswire (US)AcelRx Initiates Phase 3 Study of Zalviso® in Patients with Moderate-to-Severe Acute Post-Operative PainNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/22/20164:01PMPR Newswire (US)Findings from AcelRx Pharmaceuticals' Phase 3 SAP301 Study of ARX-04 in Abdominoplasty Patients to be Presented at Plastic Su...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/22/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/19/20166:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/16/20164:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/15/20166:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/15/20166:30AMPR Newswire (US)AcelRx Reports Positive Results for ARX-04 (sufentanil sublingual tablet, 30 mcg), Including in Elderly Patients and Patients...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/14/20164:01PMPR Newswire (US)AcelRx Pharmaceuticals to Announce Topline Results in Phase 3 Study of ARX-04 in Patients with Post-Operative Moderate-to-Sev...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/31/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in SeptemberNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/29/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Presents Results from Phase 3 Study of ARX‑04 in the Emergency Department at the International Socie...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/15/20167:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX